The Agency for Healthcare Research and Quality (AHRQ), a federal agency focused on improving healthcare, has seen its staff cut by 75%. This reduction occurred during the Trump administration's second term. Experts warn that the agency is "on the brink" due to these changes.
In July, AHRQ canceled approximately 150 grant letters, leading to the termination of over 100 research grants collectively valued at more than $250 million. These cancellations have impacted scientists in over 30 states, forcing them to stop research, lay off staff, and close programs.
Despite Congress appropriating $345 million for AHRQ for the 2026 fiscal year, a significant portion of these funds remains unspent. Only $15 million has been allocated to grants so far, contributing to the agency's operational challenges and the halt in research activities.
Health policy experts Aaron Carroll and David Atkins highlighted the loss of data, research findings, and the impact on the scientific community. They expressed concern about the future development of healthcare services researchers and called on Congress to address the situation.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
The Agency for Healthcare Research and Quality (AHRQ) has experienced a 75% staff reduction and the cancellation of over 100 research grants totaling more than $250 million. This has halted research across 30 states and raised concerns about the future of healthcare services research.